Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DNLI

Denali Therapeutics (DNLI)

Denali Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DNLI
DateTimeSourceHeadlineSymbolCompany
02/07/20225:51PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DNLIDenali Therapeutics Inc
02/07/20228:00AMGlobeNewswire Inc.Denali Therapeutics Announces Appointment of Erik Harris to Board of DirectorsNASDAQ:DNLIDenali Therapeutics Inc
02/03/20223:58PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNLIDenali Therapeutics Inc
01/18/202210:50AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNLIDenali Therapeutics Inc
01/13/20229:31AMDow Jones NewsDenali Therapeutics Shares Fall as FDA Puts Alzheimer's Study Plan on HoldNASDAQ:DNLIDenali Therapeutics Inc
01/13/20227:00AMGlobeNewswire Inc.Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) ApplicationNASDAQ:DNLIDenali Therapeutics Inc
01/10/20228:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNLIDenali Therapeutics Inc
01/10/20227:00AMGlobeNewswire Inc.Denali Therapeutics Announces Progression and Expansion of Broad Therapeutic Portfolio for Neurodegeneration and Expected Key Milestones in 2022NASDAQ:DNLIDenali Therapeutics Inc
01/07/20225:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
01/07/20225:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
01/07/20225:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
01/07/20225:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
01/06/202210:28AMTipRanksDenali Therapeutics (DNLI) Receives a Buy from Morgan StanleyNASDAQ:DNLIDenali Therapeutics Inc
11/17/20218:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNLIDenali Therapeutics Inc
11/17/20217:30AMGlobeNewswire Inc.Denali Therapeutics Announces Strategic Partner Takeda Exercises Option to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN)NASDAQ:DNLIDenali Therapeutics Inc
11/12/20213:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
11/08/20213:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
11/04/20213:09PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DNLIDenali Therapeutics Inc
11/04/20213:01PMGlobeNewswire Inc.Denali Therapeutics Reports Third Quarter 2021 Financial Results and Business HighlightsNASDAQ:DNLIDenali Therapeutics Inc
11/03/20214:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
10/13/20219:11AMPR Newswire (US)Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate ChangeNASDAQ:DNLIDenali Therapeutics Inc
10/06/20215:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
10/06/20213:01PMGlobeNewswire Inc.Denali Therapeutics Announces Positive Clinical Results and Regulatory Progress for Development Programs in Amyotrophic Lateral Sclerosis (ALS)NASDAQ:DNLIDenali Therapeutics Inc
10/05/20213:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
09/29/20218:00AMGlobeNewswire Inc.Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) MeetingNASDAQ:DNLIDenali Therapeutics Inc
09/27/20218:00AMGlobeNewswire Inc.Denali Therapeutics Appoints Katie Peng as Chief Commercial OfficerNASDAQ:DNLIDenali Therapeutics Inc
09/22/20215:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
09/17/20213:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
09/09/20218:00AMGlobeNewswire Inc.Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALSNASDAQ:DNLIDenali Therapeutics Inc
09/03/20215:54AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNLIDenali Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DNLI